CJC‑1295 + Ipamorelin – 10mg

CJC‑1295 + Ipamorelin is a dual‑peptide research formulation combining two synthetic analogues frequently used in laboratory studies of growth hormone‑related signalling and peptide synergy.

CJC‑1295 is a growth hormone‑releasing hormone (GHRH) analogue, while Ipamorelin is a growth hormone secretagogue (GHS). Together, they are used in controlled research environments to explore co‑stimulation mechanisms and peptide interaction models relevant to endocrine and metabolic pathways.

Areas of Research Interest
Peptide Synergy Studies
Used in research examining how GHRH analogues and GHS compounds interact to modulate peptide‑driven signalling cascades.

Endocrine Pathway Modelling
Employed in laboratory models investigating pituitary and hypothalamic peptide responses under controlled conditions.

Metabolic Regulation Research
Explored for its role in studies of peptide‑mediated metabolic processes and energy utilisation.

Comparative Peptide Analysis
Often included in research comparing single‑agent versus combination peptide effects on receptor activation and downstream biochemical pathways.

Technical Information
Chemical Names: CJC‑1295 (Modified GHRH analogue) + Ipamorelin (GHS pentapeptide)

Synonyms: CJC1295, Ipamorelin, CJC‑1295/Ipamorelin blend

Molecular Formula:

CJC‑1295: C₁₅₂H₂₅₂N₄₄O₄₈

Ipamorelin: C₃₈H₄₉N₉O₅

Molecular Weights:

CJC‑1295 ≈ 3367 g/mol

Ipamorelin ≈ 711 g/mol

Peptide Classification: Synthetic peptide combination for research use only

Storage Guidelines
Lyophilised peptide is stable at room temperature for short periods.

For long‑term storage, keep at –20°C or below.

After reconstitution, store at 2–8°C.

Stability depends on solvent and laboratory handling conditions.

Solubility
Soluble in sterile water, acetic acid, or aqueous buffers commonly used in peptide preparation.

References (Research Context Only)
Teichman et al., Journal of Clinical Endocrinology & Metabolism – Studies on CJC‑1295 pharmacokinetics

Bowers et al., Endocrinology – Investigations into Ipamorelin receptor activity

Laboratory reviews on peptide co‑administration models (various preclinical sources)

(Full citations available upon request. Direct links removed for compliance.)

Compliance Notice
For laboratory research use only. Not for human or animal administration.